RWE Aktiengesellschaft 30.04.2015 13:56 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of voting rights pursuant to Art. 25a, Sec. 1 WpHG We received the following notification pursuant to Art. 25a, Sec. 1 WpHG on April 29, 2015: 1. Listed company: RWE Aktiengesellschaft Opernplatz 1, 45128 Essen, Germany 2. Notifier: Morgan Stanley International Holdings Inc., Wilmington, Delaware, United States 3. Triggering event: Falling below threshold 4. Threshold(s) crossed or reached: 5% 5. Date at which the threshold is crossed or reached: 23.04.2015 6. Total amount of voting rights: 3.50% (equals 20148486 voting rights) calculated from the following total number of voting rights issued: 575745499 7. Detailed information on the voting rights proportion: Voting rights proportion based on financial/other instruments pursuant to Art. 25a, Sec. 1 WpHG: 2.11% (equals 12140446 voting rights) thereof held indirectly: 2.11% (equals 12140446 voting rights) Voting rights proportion based on financial/other instruments pursuant to Art. 25 WpHG: 1.37% (equals 7880000 voting rights) thereof held indirectly: 1.37% (equals 7880000 voting rights) Voting rights pursuant to Art. 21, 22 WpHG: 0.02% (equals 128040 voting rights) 8. Detailed information on financial/other instruments pursuant to Art. 25a, Sec. 1 WpHG: Chain of controlled undertakings: MS Equity Financing Services (Luxembourg) Sarl, Morgan Stanley B.V., Morgan Stanley International Limited, Morgan Stanley Group (Europe), Morgan Stanley UK Group, Morgan Stanley Investments (UK), Morgan Stanley & Co. International plc ISIN or name/description of the financial/other instrument: Cash-Settled Swap Maturity: Expiration date: 28.04.2015 ISIN or name/description of the financial/other instrument: Cash-Settled Swap Maturity: Expiration date: 05.05.2015 ISIN or name/description of the financial/other instrument: Cash-Settled Swap Maturity: Expiration date: 29.03.2016 ISIN or name/description of the financial/other instrument: Cash-Settled Swap Maturity: Expiration date: 02.05.2016 ISIN or name/description of the financial/other instrument: Cash-Settled Swap Maturity: Expiration date: 04.07.2016 ISIN or name/description of the financial/other instrument: Cash-Settled Swap Maturity: Expiration date: 23.01.2017 ISIN or name/description of the financial/other instrument: Cash-Settled Swap Maturity: Expiration date: 13.02.2017 ISIN or name/description of the financial/other instrument: Cash-Settled Call Option Maturity: Expiration date: 18.12.2015 ISIN or name/description of the financial/other instrument: Cash-Settled Call Option Maturity: Expiration date: 16.12.2016 ISIN or name/description of the financial/other instrument: Cash-Settled Call Option Maturity: Expiration date: 29.01.2018 ISIN or name/description of the financial/other instrument: Cash-Settled Future Maturity: Expiration date: 15.05.2015 ISIN or name/description of the financial/other instrument: Cash-Settled Put Option Maturity: Expiration date: 18.12.2015 ISIN or name/description of the financial/other instrument: Cash-Settled Put Option Maturity: Expiration date: 08.04.2021 ISIN or name/description of the financial/other instrument: Physically-Settled Put Option Maturity: Expiration date: 19.06.2015 ISIN or name/description of the financial/other instrument: Physically-Settled Put Option Maturity: Expiration date: 18.12.2015 ISIN or name/description of the financial/other instrument: Physically-Settled Put Option Maturity: Expiration date: 17.06.2016 ISIN or name/description of the financial/other instrument: Physically-Settled Put Option Maturity: Expiration date: 16.12.2016 30.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RWE Aktiengesellschaft Opernplatz 1 45128 Essen Germany Internet: www.rwe.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RWE Aktiengesellschaft: Publication according to
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Nokia Corporation's Recent Management Transaction Highlights
Nokia Corporation's Latest Management Transactions Nokia Corporation has recently announced significant management transactions that emphasize its ongoing operational strategies and technological innovations. Today, we dive into the details of one particular transaction involving a key manager in the company. Transaction Details This transaction notification is made under...
Continue Reading
Huawei's Innovative AI WAN Solution Revolutionizes Networking
Huawei's New AI WAN Solution Unveiled At the Mobile World Congress in Barcelona, Huawei introduced the AI WAN Solution, a groundbreaking development designed to revolutionize networking. Leon Wang, the President of Huawei's Data Communication Product Line, emphasized the importance of merging AI with network infrastructures. This new solution aims to enhance IP networks...
Continue Reading
Transforming Business Dreams with Innovative Software Solutions
Transforming Business Dreams with Innovative Software Solutions FM, a pioneer in custom software development augmented by AI technology, is revolutionizing how businesses approach growth and scalability. In a rapidly changing landscape, where adaptability is key, FM’s approach enables organizations to leverage generative software solutions that are more accessible than...
Continue Reading
Investment in Caesars Palace Times Square Promises Growth
Community Investment and Support for Caesars Palace Times Square During a recent public hearing, community support was overwhelmingly evident for the Caesars Palace Times Square project. Local residents, small business owners, union workers, and city leaders gathered to express their enthusiasm for a project that promises to generate significant economic growth and create...
Continue Reading
Aquestive Therapeutics Reaches Milestone with FDA Notification
Groundbreaking News from Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST), a forward-thinking pharmaceutical company dedicated to enhancing patient care through innovative drug delivery solutions, has officially received word from the U.S. Food and Drug Administration (FDA) that no advisory committee meeting will be required for the New Drug Application...
Continue Reading